Nomura Research Institute, Ltd. (NRILY)
USD 29.48
(-0.3%)
USD 29.48
(-0.3%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 736.55 Billion | 692.16 Billion | 611.63 Billion | 550.33 Billion | 528.72 Billion | 501.24 Billion |
| Cost of Revenue | 475.54 Billion | 452.33 Billion | 395.56 Billion | 364.53 Billion | 346.1 Billion | 342.15 Billion |
| Gross Profit | 261 Billion | 239.82 Billion | 216.07 Billion | 185.79 Billion | 182.62 Billion | 159.09 Billion |
| Operating Expenses | 140.59 Billion | 130.84 Billion | 112.8 Billion | 98.36 Billion | 97.49 Billion | 87.64 Billion |
| Selling, General and Administrative Expenses | 142.35 Billion | 125.93 Billion | 107.8 Billion | 93.89 Billion | 93.18 Billion | 83.98 Billion |
| Research and Development Expenses | - | 4.9 Billion | 4.99 Billion | 4.46 Billion | 4.31 Billion | 3.66 Billion |
| Other Expenses | -1.75 Billion | - | - | - | 274 Million | 21 Million |
| Cost and Expenses | 616.14 Billion | 583.18 Billion | 508.36 Billion | 462.9 Billion | 443.59 Billion | 429.8 Billion |
| Operating Income | 120.41 Billion | 108.98 Billion | 103.27 Billion | 87.43 Billion | 85.12 Billion | 71.44 Billion |
| Interest Expense | 6.65 Billion | 5.55 Billion | 2.67 Billion | 1.9 Billion | 1.06 Billion | 441 Million |
| Income Tax Expense | 37.06 Billion | 32 Billion | 32.87 Billion | 18.49 Billion | 26.38 Billion | 25.21 Billion |
| Earnings before Tax | 116.44 Billion | 108.04 Billion | 104.46 Billion | 71.01 Billion | 85.47 Billion | 76.74 Billion |
| Net Income | 79.64 Billion | 76.3 Billion | 71.44 Billion | 52.86 Billion | 58.19 Billion | 50.93 Billion |
| Earnings Per Share Basic | 136.84 | 128.92 | 120.57 | 88.34 | 91.86 | 72.11 |
| Earnings Per Share Diluted | 136.83 | 128.88 | 120.34 | 88.12 | 91.62 | 71.94 |
| Weighted Average Shares Outstanding | 582.01 Million | 591.91 Million | 592.56 Million | 598.43 Million | 633.52 Million | 706.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 582.03 Million | 592.07 Million | 593.71 Million | 599.92 Million | 635.16 Million | 707.96 Million |
| Gross Margin | 0.35 | 0.35 | 0.35 | 0.34 | 0.35 | 0.32 |
| EBIT Margin | 0.23 | 0.22 | 0.24 | 0.23 | 0.24 | 0.21 |
| Profit Margin | 0.11 | 0.11 | 0.12 | 0.10 | 0.11 | 0.10 |
| EBITDA | 167.09 Billion | 154.67 Billion | 144.6 Billion | 123.81 Billion | 124.51 Billion | 105.8 Billion |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.17 | 0.16 | 0.16 | 0.14 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 186.53 Billion | 736.55 Billion | 187.95 Billion | 185.35 Billion | 176.7 Billion | 692.16 Billion |
| Cost of Revenue | 120.51 Billion | 475.54 Billion | 121.34 Billion | 120.15 Billion | 113.53 Billion | 452.33 Billion |
| Gross Profit | 66.02 Billion | 261 Billion | 66.6 Billion | 65.2 Billion | 63.17 Billion | 239.82 Billion |
| Operating Expenses | 37.01 Billion | 142.35 Billion | 36.19 Billion | 33.8 Billion | 35.34 Billion | 130.84 Billion |
| Selling, General and Administrative Expenses | 35.4 Billion | - | 34.85 Billion | 32.34 Billion | 34.45 Billion | - |
| Research and Development Expenses | 1.61 Billion | - | 1.34 Billion | 1.46 Billion | 886 Million | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 157.52 Billion | 617.9 Billion | 157.54 Billion | 153.95 Billion | 148.88 Billion | 583.18 Billion |
| Operating Income | 29.01 Billion | 118.65 Billion | 30.41 Billion | 31.4 Billion | 27.82 Billion | 108.98 Billion |
| Interest Expense | 1.91 Billion | 6.65 Billion | 1.62 Billion | 1.63 Billion | 1.47 Billion | 5.55 Billion |
| Income Tax Expense | 9.22 Billion | 37.06 Billion | 8.17 Billion | 10.36 Billion | 9.28 Billion | 32 Billion |
| Earnings before Tax | 27.79 Billion | 116.44 Billion | 31.4 Billion | 30.81 Billion | 26.43 Billion | 108.04 Billion |
| Net Income | 18.55 Billion | 79.64 Billion | 23.43 Billion | 20.45 Billion | 17.21 Billion | 76.3 Billion |
| Earnings Per Share Basic | 32.23 | - | 40.65 | 35.00 | 29.29 | - |
| Earnings Per Share Diluted | 32.22 | - | 40.63 | 34.98 | 29.28 | - |
| Weighted Average Shares Outstanding | 576.2 Million | 581.74 Million | 576.35 Million | 584.31 Million | 590.34 Million | 591.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 576.25 Million | 582.03 Million | 576.62 Million | 584.64 Million | 590.71 Million | 592.07 Million |
| Gross Margin | 0.35 | 0.35 | 0.35 | 0.35 | 0.36 | 0.35 |
| EBIT Margin | 0.22 | - | 0.23 | 0.23 | 0.22 | - |
| Profit Margin | 0.10 | 0.11 | 0.12 | 0.11 | 0.10 | 0.11 |
| EBITDA | 41.11 Billion | - | 42.71 Billion | 43.43 Billion | 39.54 Billion | - |
| Earnings Before Tax Margin | 0.16 | 0.16 | 0.16 | 0.17 | 0.16 | 0.16 |
7827
BIOKA
CKNHF
000717
AGM-A
PRVU